Literature DB >> 18362891

P73 and caspase-cleaved p73 fragments localize to mitochondria and augment TRAIL-induced apoptosis.

A E Sayan1, B S Sayan, V Gogvadze, D Dinsdale, U Nyman, T M Hansen, B Zhivotovsky, G M Cohen, R A Knight, G Melino.   

Abstract

The p73 protein, a member of the p53 family, has both developmental and tumorigenic functions. Here we show that p73 is cleaved by caspase-3 and -8 both in vitro and in vivo during apoptosis elicited by DNA-damaging drugs and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor ligation. TAp73 and some of its cleavage products are localized to mitochondria. siRNA-mediated downregulation of p73 expression induced a small but significant change in the susceptibility of HCT116 cells to TRAIL-induced apoptosis. A transcription-deficient mutant of TAp73 enhanced TRAIL-induced apoptosis suggesting that p73 protein has transcription-independent functions during death receptor-mediated apoptosis. Additionally, recombinant p73 protein induced cytochrome c release from isolated mitochondria providing evidence that nonnuclear p73 may have additional functions in the progression of apoptosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18362891     DOI: 10.1038/onc.2008.64

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  23 in total

1.  The p53 family: guardians of maternal reproduction.

Authors:  Arnold J Levine; Richard Tomasini; Frank D McKeon; Tak W Mak; Gerry Melino
Journal:  Nat Rev Mol Cell Biol       Date:  2011-04       Impact factor: 94.444

2.  Overexpression of the ∆Np73 isoform is associated with centrosome amplification in brain tumor cell lines.

Authors:  Erika Mikulenkova; Jakub Neradil; Karel Zitterbart; Jaroslav Sterba; Renata Veselska
Journal:  Tumour Biol       Date:  2015-04-25

3.  p73 gene in dopaminergic neurons is highly susceptible to manganese neurotoxicity.

Authors:  Dong-Suk Kim; Huajun Jin; Vellareddy Anantharam; Richard Gordon; Arthi Kanthasamy; Anumantha G Kanthasamy
Journal:  Neurotoxicology       Date:  2016-04-20       Impact factor: 4.294

4.  Cytoplasmic pro-apoptotic function of the tumor suppressor p73 is mediated through a modified mode of recognition of the anti-apoptotic regulator Bcl-XL.

Authors:  Mi-Kyung Yoon; Bu-Yeon Kim; Ji-Young Lee; Ji-Hyang Ha; Sung Ah Kim; Dong-Hwa Lee; Min-Sung Lee; Mi-Kyung Lee; Jin Sun Choi; Jin Hwa Cho; Jeong-Hoon Kim; Sunhong Kim; Jaewhan Song; Sung Goo Park; Byoung Chul Park; Kwang-Hee Bae; Sang Un Choi; Seung-Wook Chi
Journal:  J Biol Chem       Date:  2018-11-14       Impact factor: 5.157

5.  GRAMD4 mimics p53 and mediates the apoptotic function of p73 at mitochondria.

Authors:  K John; V Alla; C Meier; B M Pützer
Journal:  Cell Death Differ       Date:  2010-12-03       Impact factor: 15.828

Review 6.  WWOX gene and gene product: tumor suppression through specific protein interactions.

Authors:  Zaidoun Salah; Rami Aqeilan; Kay Huebner
Journal:  Future Oncol       Date:  2010-02       Impact factor: 3.404

7.  Differential control of TAp73 and DeltaNp73 protein stability by the ring finger ubiquitin ligase PIR2.

Authors:  Berna S Sayan; Ai Li Yang; Franco Conforti; Paola Tucci; Maria Cristina Piro; Gareth J Browne; Massimiliano Agostini; Sergio Bernardini; Richard A Knight; Tak W Mak; Gerry Melino
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-06       Impact factor: 11.205

Review 8.  A balancing act: orchestrating amino-truncated and full-length p73 variants as decisive factors in cancer progression.

Authors:  D Engelmann; C Meier; V Alla; B M Pützer
Journal:  Oncogene       Date:  2014-11-10       Impact factor: 9.867

Review 9.  The p53 family and programmed cell death.

Authors:  E C Pietsch; S M Sykes; S B McMahon; M E Murphy
Journal:  Oncogene       Date:  2008-10-27       Impact factor: 9.867

10.  The cyclin-dependent kinase inhibitor 5, 6-dichloro-1-beta-D-ribofuranosylbenzimidazole induces nongenotoxic, DNA replication-independent apoptosis of normal and leukemic cells, regardless of their p53 status.

Authors:  Valentina Turinetto; Paola Porcedda; Luca Orlando; Mario De Marchi; Antonio Amoroso; Claudia Giachino
Journal:  BMC Cancer       Date:  2009-08-12       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.